EUVIMEDEUVIMED entdecken
Leserbrief

Glycolytic activity and in vitro effect of the pyruvate kinase activator AG ‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study

Bruno Fattizzo iD, Cristina Vercellati, Anna Marcello, Parija Patel, Megan Wind-Rotolo, Loredana Pettine iD, Marcella Bonanomi, Daniela Gaglio, Marta Bortolotti iD, Claudia Leoni, Elisa Fermo, Paola Bianchi iD und 3 weitere

American Journal of Hematology · 2024-06 · 99 (6) · 1201-1204

DOI: 10.1002/ajh.27300 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 02.04.2024. Verfasst von Bruno Fattizzo und 14 weiteren Autor:innen. Beteiligte Einrichtung: SC Ematologia, SS Fisiopatologia delle Anemie, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Glycolysis, Pyruvate Kinase, Erythrocytes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: Agios Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesGlycolysisPyruvate KinaseErythrocytesHumansAgedMaleFemaleMiddle AgedProof of Concept StudyAged, 80 and over

Substanzen

Pyruvate Kinase

Autor:innen und Institutionen

  • SC Ematologia, SS Fisiopatologia delle Anemie, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Agios Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
  • Institute of Molecular Bioimaging and Physiology of the Italian National Research Council (IBFM-CNR), Segrate (MI), Italy.
  • ISBE Elixir European Infrastructure for Systems Biology, Milan, Italy.

ORCID-Profile: Bruno Fattizzo, Loredana Pettine, Marta Bortolotti, Paola Bianchi, Anna Zaninoni, Wilma Barcellini

Förderung

  • Agios Pharmaceuticals

Zitieren

APA

Fattizzo, B., Vercellati, C., Marcello, A., Patel, P., Wind-Rotolo, M., Pettine, L., Bonanomi, M., Gaglio, D., Bortolotti, M., Leoni, C., Fermo, E., Bianchi, P., Zaninoni, A., Passamonti, F., & Barcellini, W. (2024). Glycolytic activity and in vitro effect of the pyruvate kinase activator AG ‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study. American Journal of Hematology, 99(6), 1201-1204. https://doi.org/10.1002/ajh.27300

Vancouver

Fattizzo B, Vercellati C, Marcello A, Patel P, Wind-Rotolo M, Pettine L, et al. Glycolytic activity and in vitro effect of the pyruvate kinase activator AG ‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study. American Journal of Hematology. 2024;99(6):1201-1204. doi:10.1002/ajh.27300

BibTeX
@article{Fattizzo2024,
  author = {Fattizzo, Bruno and Vercellati, Cristina and Marcello, Anna and Patel, Parija and Wind-Rotolo, Megan and Pettine, Loredana and Bonanomi, Marcella and Gaglio, Daniela and Bortolotti, Marta and Leoni, Claudia and Fermo, Elisa and Bianchi, Paola and Zaninoni, Anna and Passamonti, Francesco and Barcellini, Wilma},
  title = {Glycolytic activity and in vitro effect of the pyruvate kinase activator AG ‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study},
  journal = {American Journal of Hematology},
  year = {2024},
  volume = {99},
  number = {6},
  pages = {1201--1204},
  doi = {10.1002/ajh.27300}
}
Kostenlos starten →